Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGSWW) Deferred Taxes (2022 - 2025)

GeneDx Holdings has reported Deferred Taxes over the past 4 years, most recently at $246000.0 for Q3 2025.

  • Quarterly results put Deferred Taxes at $246000.0 for Q3 2025, up 623.4% from a year ago — trailing twelve months through Sep 2025 was $424000.0 (up 158.08% YoY), and the annual figure for FY2024 was -$343000.0, up 62.96%.
  • Deferred Taxes for Q3 2025 was $246000.0 at GeneDx Holdings, up from -$245000.0 in the prior quarter.
  • Over the last five years, Deferred Taxes for WGSWW hit a ceiling of $447000.0 in Q1 2025 and a floor of -$49.1 million in Q2 2022.
  • Median Deferred Taxes over the past 4 years was -$123000.0 (2022), compared with a mean of -$3.6 million.
  • Biggest five-year swings in Deferred Taxes: plummeted 890.38% in 2023 and later surged 645.12% in 2025.
  • GeneDx Holdings' Deferred Taxes stood at $52000.0 in 2022, then plummeted by 890.38% to -$411000.0 in 2023, then soared by 94.16% to -$24000.0 in 2024, then soared by 1125.0% to $246000.0 in 2025.
  • The last three reported values for Deferred Taxes were $246000.0 (Q3 2025), -$245000.0 (Q2 2025), and $447000.0 (Q1 2025) per Business Quant data.